合計 50 件の最近のインサイダー取引記録が記録されています Atrium Therapeutics, Inc. (RNA), 内訳は 17 件の買い および 29 件の売り. インサイダー買い総額は $16.86M インサイダー売り総額は $8.27M.
最近活動のある主要インサイダーには Gallagher Kathleen P., Flanagan W. Michael, Levin Arthur A. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — RNA
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-17 |
Gallagher Kathleen P. |
Chief Program Officer |
情報に基づく売り |
911 |
$30.24 |
$27.55K |
50,392 |
| 2025-06-11 |
Flanagan W. Michael |
Chief Scientific Officer |
情報に基づく売り |
20,000 |
$32.88 |
$657.69K |
80,195 |
| 2025-06-10 |
Levin Arthur A |
Director |
RSU 付与（制限付株式） |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Boess Carsten |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kaye Edward M. Md |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Wilson Troy Edward |
Director |
RSU 付与（制限付株式） |
10,034 |
$33.62 |
$337.34K |
10,034 |
| 2025-06-10 |
Henig Noreen |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Thompson Tamar |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Kim Jean Jinsun |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-10 |
Skerjanec Simona |
Director |
RSU 付与（制限付株式） |
6,692 |
- |
- |
6,692 |
| 2025-06-02 |
Gallagher Kathleen P. |
Chief Program Officer |
オプション行使（売却） |
5,875 |
$16.65 |
$97.82K |
22,596 |
| 2025-05-01 |
Gallagher Kathleen P. |
Chief Program Officer |
オプション行使（売却） |
5,875 |
$16.65 |
$97.82K |
28,471 |
| 2025-04-01 |
Gallagher Kathleen P. |
Chief Program Officer |
オプション行使（売却） |
5,546 |
$14.70 |
$81.53K |
13,829 |
| 2025-03-20 |
Maclean Michael F |
Chief Financial Officer |
情報に基づく売り |
7,935 |
$31.06 |
$246.42K |
96,720 |
| 2025-03-20 |
Boyce Sarah |
President and CEO |
情報に基づく売り |
31,540 |
$31.06 |
$979.56K |
305,871 |
| 2025-03-20 |
Hughes Steven George |
Chief Medical Officer |
情報に基づく売り |
9,578 |
$31.06 |
$297.49K |
72,850 |
| 2025-03-20 |
Flanagan W. Michael |
Chief Scientific Officer |
情報に基づく売り |
11,780 |
$31.06 |
$365.87K |
80,195 |
| 2025-03-20 |
Mccarthy Teresa |
Chief Human Resources Officer |
情報に基づく売り |
7,778 |
$31.06 |
$241.58K |
97,130 |
| 2025-03-11 |
Flanagan W. Michael |
Chief Scientific Officer |
情報に基づく売り |
20,000 |
$30.13 |
$602.61K |
91,975 |
| 2025-03-03 |
Gallagher Kathleen P. |
Chief Program Officer |
オプション行使（売却） |
5,875 |
$14.70 |
$86.36K |
19,375 |
| 2025-02-03 |
Gallagher Kathleen P. |
Chief Program Officer |
オプション行使（売却） |
5,875 |
$16.65 |
$97.82K |
34,675 |
| 2025-01-22 |
Gallagher Kathleen P. |
Chief Program Officer |
情報に基づく売り |
5,629 |
$30.16 |
$169.78K |
50,554 |
| 2025-01-21 |
Levin Arthur A |
Director |
情報に基づく売り |
1,872 |
$28.60 |
$53.54K |
12,958 |
| 2025-01-21 |
Maclean Michael F |
Chief Financial Officer |
情報に基づく売り |
1,665 |
$28.59 |
$47.61K |
104,655 |
| 2025-01-21 |
Boyce Sarah |
President and CEO |
情報に基づく売り |
5,659 |
$28.59 |
$161.82K |
337,411 |
| 2025-01-21 |
Hughes Steven George |
Chief Medical Officer |
情報に基づく売り |
2,032 |
$28.59 |
$58.1K |
82,428 |
| 2025-01-21 |
Flanagan W. Michael |
Chief Scientific Officer |
情報に基づく売り |
1,812 |
$28.59 |
$51.81K |
91,975 |
| 2025-01-21 |
Mccarthy Teresa |
Chief Human Resources Officer |
情報に基づく売り |
1,221 |
$28.60 |
$34.92K |
104,908 |
| 2025-01-21 |
Gallagher Kathleen P. |
Chief Program Officer |
情報に基づく売り |
1,817 |
$28.59 |
$51.95K |
56,183 |
| 2025-01-06 |
Maclean Michael F |
Chief Financial Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Moriarty John B |
Chief Legal Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Boyce Sarah |
President and CEO |
RSU 付与（制限付株式） |
165,000 |
$31.42 |
$5.18M |
165,000 |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
不明 |
315,000 |
$9.05 |
$2.85M |
- |
| 2025-01-06 |
Mosbrooker Eric |
Chief Commercial Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
不明 |
84,625 |
$15.96 |
$1.35M |
- |
| 2025-01-06 |
Hughes Steven George |
Chief Medical Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Flanagan W. Michael |
Chief Scientific Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Mccarthy Teresa |
Chief Human Resources Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
不明 |
16,000 |
$44.00 |
$704K |
- |
| 2025-01-06 |
Gallagher Kathleen P. |
Chief Program Officer |
RSU 付与（制限付株式） |
50,000 |
$31.42 |
$1.57M |
50,000 |
| 2025-01-06 |
Calderaro Charles Iii |
Officer |
不明 |
- |
- |
- |
- |
| 2025-01-06 |
Calderaro Charles Iii |
Chief Technical Officer |
RSU 付与（制限付株式） |
40,000 |
- |
- |
40,000 |
| 2024-12-18 |
Maclean Michael F |
Chief Financial Officer |
情報に基づく売り |
11,151 |
$32.66 |
$364.19K |
82,942 |
| 2024-12-18 |
Boyce Sarah |
President and CEO |
情報に基づく売り |
31,855 |
$32.66 |
$1.04M |
265,308 |
| 2024-12-18 |
Flanagan W. Michael |
Csto |
情報に基づく売り |
12,742 |
$32.66 |
$416.15K |
72,647 |
| 2024-12-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
情報に基づく売り |
11,151 |
$32.66 |
$364.19K |
82,867 |
| 2024-12-16 |
Mccarthy Teresa |
Chief Human Resources Officer |
オプション行使（売却） |
25,000 |
$14.22 |
$355.5K |
57,500 |
| 2024-12-11 |
Flanagan W. Michael |
Csto |
情報に基づく売り |
24,000 |
$35.77 |
$858.4K |
85,389 |
| 2024-11-19 |
Levin Arthur A |
Director |
オプション行使（売却） |
3,323 |
$1.24 |
$4.12K |
- |
| 2024-11-18 |
Mccarthy Teresa |
Chief Human Resources Officer |
オプション行使（売却） |
25,000 |
$14.22 |
$355.5K |
82,500 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
